Pain, Cognitive Dysfunction in SLE Mediated by Sleep Disturbance, Depression
The relationship between pain and cognitive dysfunction was explained by sleep disturbance and depressive symptoms.
Systemic Lupus Erythematosus
No Increased Risk of SLE With Current Use of Statin Therapy
No association was found between current statin use and the risk of developing systemic lupus erythematosus.
SLE Disease Flares Associated With Childhood Diffuse Alveolar Hemorrhage
Diffuse alveolar hemorrhage in childhood-onset SLE is associated with serious disease flares, and is complicated by sepsis and high mortality rate.
New SLE Candidate Criteria
Researchers have created a set of 21 candidate criteria for systemic lupus erythematosus as apart of a multiphase development of a set of criteria for the disease.
Disease Activity Biomarker in Pediatric SLE
Fractional exhaled nitric oxide monitoring may provide a potential biomarker of disease activity and signify the emergency of pulmonary involvement in children with SLE.
Association Between Low Levels of Blimp-1 Protein, Lupus
Researchers from the Feinstein Institute for Medical Research may have identified a potential cause for lupus, which may lead to new treatment options.
Biomarkers of Increased PAH Risk Identified in Patients With SLE
The risk for death associated with SLE remains high for patients with SLE-associated PAH and researchers have identified the biomarkers that may lead to early detection.
Cardiometabolic and Mortality Risks in Chronic Inflammatory Disorders
Certain inflammatory disorders may increase the risk for cardiometabolic events and all-cause mortality.
Risk Factor for Osteonecrosis in Patients With SLE
Cumulative steroid dosage is a risk factor for the development of osteonecrosis, which is the most frequent type of damage in lupus patients.
Subcutaneous Belimumab Effective on SLE
Adjunctive subcutaneous belimumab plus standard care improves SLE Responder Index response and decreases disease flares
Next post in Rheumatology
